What it is
A long-acting GHRH analog incorporating a drug affinity complex (DAC) that binds serum albumin. Supplied as a lyophilized powder.
How it works
Binds the GHRH receptor on pituitary somatotrophs. The DAC modification covalently binds albumin in circulation, dramatically extending half-life and producing sustained elevation of GH and IGF-1.
Where it's used
Studied in early clinical research as a long-acting GHRH analog.
Regulatory status
Not FDA-approved; research compound.
Reconstitution
Supplied as a lyophilized powder requiring reconstitution with bacteriostatic water prior to use.
Tracking it
CJC-1295 with DAC is injectable, so two things matter in a log: when you dosed and where. Rotating sites and writing both down prevents the classic “did I already pin the left side?” problem. with a half-life of about 8 days (192 h), a dose log also lets a tracker model the relative amount still in your system between doses.
Source
Public reference
Last reviewed 2026-06-11